Carcinoma

• Celgene

  Company1 trialPhase 4143 people

• Xoft

  Company1 trialPhase 463 people

• Novartis Pharmaceuticals Corporation

  Company3 trialsPhase 3984 people

• Sanofi

  Company2 trialsPhase 3988 people

• Bayer

  Company2 trialsPhase 3861 people

• Amgen

  Company2 trialsPhase 3411 people

• Abbott

  Company1 trialPhase 31,035 people

• Shanghai Henlius Biotech

  Company1 trialPhase 3643 people

National Cancer InstituteUS$32.9mNational Institute on AgingUS$1.4mJapan Society for the Promotion of ScienceJP¥40.2m

• Access EquiTy and Causal EffecTs of GluCagon LiKe Peptide 1 Agonist on HepatoCellular Carcinoma PreveNtion and SurvivOrship in Patients With Cirrhosis

  American Cancer SocietyOhio State University946k2026–2030

• Improved Ultrasound for Hepatocellular Carcinoma Screening

  National Cancer InstituteVanderbilt UniversityUS$635k2026–2031

• The Impact of Genetic Ancestry on Racial Disparities in Hepatocellular Carcinoma Risk and Mortality

  National Cancer InstituteUniversity of Miami School of MedicineUS$237.1k2022–2027

• Environment, Genetics, and Epigenetics of Hepatocellular Carcinoma Risk in the US

  National Cancer InstituteColumbia University Health SciencesUS$717.9k2026–2031

• Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome

  National Cancer InstituteBaylor College of MedicineUS$1.2m2022–2027

• CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention

  National Cancer InstituteWeill Medical Coll of Cornell UnivUS$457.2k2023–2028

• TOWARD TRANSLATION OF NANOPHOTONIC SINGLE EXOSOME LIQUID BIOPSY FOR HEPATOCELLULAR CARCINOMA SCREENING AND DIAGNOSIS

  National Cancer InstituteUniversity of HoustonUS$656.9k2026–2030

• Clinical Validation Center for Hepatocellular Carcinoma

  National Cancer InstituteUT Southwestern Medical CenterUS$1m2022–2027

• Exosomal biomarkers for the early detection of hepatocellular carcinoma

  National Cancer InstituteBeckman Research Institute/city of HopeUS$727.9k2023–2028

• Genetic Epidemiology of Hepatocellular Carcinoma in African Americans

  National Cancer InstituteBaylor College of MedicineUS$366k2023–2028